Hemab Therapeutics Holdings, Inc.

COAG · NasdaqGS

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

–

Growth

Health

–

Risk

–

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders10.8%

Institutions92.1%

Public / Other

	2025-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$0
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$63.91M

	You	Peer avg
P/E	–	13.7
Revenue Growth	–	+85.6%
ROE	–	-11.9%

Hemab Therapeutics Holdings, Inc.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Peer Comparison